$1.00+0.06 (+6.17%)
At close: Nov 17, 2026, 4:00 PM ET· Nasdaq · USD
Geron (GERN) Income Statement
Is this a real, growing, cash-generative business, or a story propped up by accounting?
Sources Company filings FilingsHow we compute thisNot investment advice
7 figures withheld by our checks. Each blank figure names its reason.
Business engineGrowing fast: revenue compounds ~239.0%/yr (FY21→FY25), net margin −45.4%. Worth your attention in FY25: Share count (+103.5%). Visible in the receipts below.
The four lines that matter · FY21–FY25
Revenue ($M)▲138.8%
183.9
FY21→FY25CAGR +239.0%/yr
Net income ($M)▲52.2%
−83.5
FY21→FY25CAGR —
Free cash flow ($M)▲49.3%
−111.1
FY21→FY25CAGR —
Diluted EPS▲51.9%
−0.13
FY21→FY25CAGR —
What the receipts whisper · what a headline number hides
Share count
+103.5%
327.6mn → 666.7mn diluted shares since FY21. Rising share count dilutes EPS. Growth must outrun it.
Capex
$49.0K
−92.8% YoY in FY25 · 0.0% of revenue.
What the income statement says · FY21–FY25
Where every revenue dollar goes · FY25 ($M)
-45¢ of every revenue dollar becomes profit. The biggest cost lever is operating expenses.
Margin trend · direction beats level Gross Operating Net
Net margin -45.4% is below the sector median.
The receipt · income statement · FY21–FY25 USD thousands except per-share & ratios · hover a line for its definition
USD thousands except per-share & ratios
| Line item | TTM † | FY25 | FY24 | FY23 | FY22 | FY21 | YoY | CAGR 21→25 |
|---|---|---|---|---|---|---|---|---|
| Revenue & profitability | ||||||||
Revenue | 217,522.0 | 183,881.0 | 76,994.0 | 0.0 | 0.0 | 1,393.0 | ▲138.8% | +239.0% |
Cost of revenue | 18,289.0 | 4,745.0 | 1,256.0 | 0.0 | 0.0 | 0.0 | ▲277.8% | — |
Gross profit | 199,233.0 | 179,136.0 | 75,738.0 | 0.0 | 0.0 | —A | ▲136.5% | — |
Research & development | 63,244.0 | 71,433.0 | 103,738.0 | 125,046.0 | 95,518.0 | 85,727.0 | ▼31.1% | −4.5% |
Selling, general & admin | 151,658.0 | 159,256.0 | 145,732.0 | 69,135.0 | 43,628.0 | 29,665.0 | ▲9.3% | +52.2% |
Total operating expenses | 231,312.0 | 247,721.0 | 249,470.0 | 194,181.0 | 139,146.0 | 115,392.0 | ▼0.7% | +21.0% |
Operating incomefeeds ROC rank | −32,079.0 | −68,585.0 | −173,732.0 | −193,944.0 | −138,550.0 | −113,999.0 | ▲60.5% | — |
Other income, net | −15,755.0 | −14,915.0 | −840.0 | 9,817.0 | −3,351.0 | −2,113.0 | — | — |
Pretax income | −47,834.0 | −83,500.0 | −174,572.0 | −184,127.0 | −141,901.0 | −116,112.0 | ▲52.2% | — |
Net incomePiotroski ROA ✕feeds Buffett Quality owner earnings | −47,834.0 | −83,500.0 | −174,572.0 | −184,127.0 | −141,901.0 | −116,112.0 | ▲52.2% | — |
| Per share | ||||||||
Diluted EPSbuyback-sensitive | −0.08 | −0.13 | −0.27 | −0.32 | −0.37 | −0.35 | ▲51.9% | — |
Diluted shares (mn) | 674.05 | 666.66 | 646.03 | 570.65 | 380.78 | 327.63 | ▲3.2% | +19.4% |
| Margins | ||||||||
Gross margin88th pct in Healthcare | 91.6% | 97.4% | 98.4% | — | — | —A | ▼0.9pp | — |
Operating margin | −14.7% | −37.3% | −225.6% | — | — | −8183.7% | ▲188.3pp | — |
Net margin22nd pct in Healthcare | −22.0% | −45.4% | −226.7% | — | — | −8335.4% | ▲181.3pp | — |
† TTM = trailing four quarters through 2026-09-30.A Withheld: cost of revenue is not on file, so the gross margin is not measured.
5 more years of statements and CSV export are on Premium, and 8 more on Ultimate.Premium · $119/yr · 7-day trial · cancel anytimeUnlock with Premium →
These lines feed the tenet checklists: see which gates passTenets →Margins & returns continue as sector-ranked ratiosStatistics →
Annual report filed 2026-03-02 · view filings on SEC EDGAR ↗ · reported currency USD · as-filed figures may be later restated.
Statements normalized in our fundamentals DB · Not investment advice.
Statements normalized in our fundamentals DB · Not investment advice.
Common questions
What was Geron's revenue last fiscal year?
Geron reported revenue of $183.9M in fiscal 2025, up 138.8% from fiscal 2024.
What was Geron's net income?
Geron reported net income of −$83.5M in fiscal 2025, a net margin of −45.4%.
Annual and quarterly statements as filed, normalized into one comparable shape · Not investment advice.

